Clinical Trial Update: A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA) [Phase 4]

View source ↗

Summary

Phase 4 study VISARA evaluated the effects of RoActemra/Actemra (tocilizumab) on immune responses to vaccination in patients with rheumatoid arthritis on backgr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RoActemra/Actemra (tocilizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2012-12-07